A post-hoc analysis of the negative symptom factor score in a proof-of-concept study of glycine reuptake inhibitor bitopertin in schizophrenia

被引:4
|
作者
Umbricht, D. [1 ]
Lentz, E. [2 ]
Santarelli, L. [3 ]
Lalonde, J. [4 ]
机构
[1] F Hoffmann La Roche Ltd, Basel, Switzerland
[2] Genentech Inc, Biometr, San Francisco, CA 94080 USA
[3] F Hoffmann La Roche Ltd, Neurosci, Basel, Switzerland
[4] F Hoffmann La Roche Ltd, Div Pharmaceut, Basel, Switzerland
关键词
D O I
10.1016/S0924-977X(12)70475-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S311 / S311
页数:1
相关论文
共 50 条
  • [41] Timing and Durability of Dysphagia Symptom Response to Dupilumab in Patients With Eosinophilic Esophagitis: Post-Hoc Analysis of Part C of the LIBERTY EoE TREET Study
    Dellon, Evan S.
    Chehade, Mirna
    Bredenoord, Arjan
    Spergel, Jonathan M.
    Xia, Changming
    Tilton, Sarette T.
    McCann, Eilish
    Pela, Tiffany
    Raphael, Bram P.
    Jacob-Nara, Juby A.
    Radwan, Amr
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S474 - S475
  • [42] Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study
    Reddel, Helen K.
    Busse, William W.
    Pedersen, Soren
    Tan, Wan C.
    Chen, Yu-Zhi
    Jorup, Carin
    Lythgoe, Dan
    O'Byrne, Paul M.
    LANCET, 2017, 389 (10065): : 157 - 166
  • [43] Pilot study of cardio-vascular risks, insulin resistance and neurocognition in neuroleptic-induced Parkinsonism in schizophrenia: Post-hoc analysis of RCT study
    Raheb, H.
    Chiu, S.
    Cernovsky, Z.
    Terpstra, K.
    Vaughese, J.
    Jirui, H.
    Bureau, Y.
    John, C.
    Husni, M.
    Campbell, R.
    MOVEMENT DISORDERS, 2015, 30 : S297 - S297
  • [44] Sensitization to Aspergillus Fumigatus as a Risk Factor for Worse Outcome in Acute Exacerbations of COPD: A Post-Hoc Analysis of the Bace-Study
    Gyselinck, I.
    Vermeersch, K.
    Everaerts, S.
    Verleden, S.
    Janssens, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [45] EFFICACY OF PHOSPHODIESTERASE TYPE 5 INHIBITOR TREATMENT IN MEN WITH ERECTILE DYSFUNCTION AND METABOLIC SYNDROME: A POST-HOC ANALYSIS OF THE VARDENAFIL STATIN STUDY
    Miner, Martin
    Barnes, Allison
    Janning, Stephen
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 18 - 18
  • [46] Bayesian Optimization of Machine Learning Classification of Resting-State EEG Microstates in Schizophrenia: A Proof-of-Concept Preliminary Study Based on Secondary Analysis
    Keihani, Ahmadreza
    Sajadi, Seyed Saman
    Hasani, Mahsa
    Ferrarelli, Fabio
    BRAIN SCIENCES, 2022, 12 (11)
  • [47] KarXT treatment improves cognitive performance in cognitively impaired patients with schizophrenia: a post-hoc analysis of the phase 2 EMERGENT-1 study
    Sauder, C.
    Allen, L.
    Baker, E.
    Granger, K.
    Brier, A.
    Kavanagh, S.
    Marcus, R.
    Paul, S.
    Miller, A.
    Brannan, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S580 - S581
  • [48] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Correll, Christoph
    Goldman, Robert
    Tocco, Michael
    Pikalov, Andrei
    Hsu, Jay
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S293 - S294
  • [49] Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study
    Potkin, Steven G.
    Loze, Jean-Yves
    Forray, Carlos
    Baker, Ross A.
    Sapin, Christophe
    Peters-Strickland, Timothy
    Beillat, Maud
    Nylander, Anna-Greta
    Hertel, Peter
    Schmidt, Simon Nitschky
    Ettrup, Anders
    Eramo, Anna
    Hansen, Karina
    Naber, Dieter
    PLOS ONE, 2017, 12 (08):
  • [50] IMPACT OF DISEASE SEVERITY ON DURATION OF HOSPITALIZATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH OLANZAPINE OR HALOPERIDOL IN GERMANY: POST-HOC ANALYSIS OF DATA COLLECTED IN THE GEO STUDY
    Clouth, J.
    Schmidt, P.
    Moeser, G.
    Eichmann, F.
    Breitscheidel, L.
    VALUE IN HEALTH, 2009, 12 (07) : A354 - A354